Efficacy of BiPAP combined with tiotropium bromide and COPD treatment and nursing intervention in moderate to severe stable phase
10.3969/j.issn.1005-1678.2017.09.056
- VernacularTitle:BiPAP联合噻托溴铵和信必可在中重度稳定期COPD治疗与护理干预效果分析
- Author:
Minjiao LIANG
;
Dan ZHU
;
Shuxian CHEN
- Keywords:
bi level noninvasive positive pressure ventilation;
tiotropium bromide;
symbicort;
COPD
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(9):133-134,136
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the level of clinical treatment in severe stable double COPD noninvasive positive pressure ventilation (BiPAP) + tiotropium + Symbicort regimen effect. Methods 210 patients with moderate to severe COPD patients as the research object, divided into group I, group II, group III, 1 BiPAP + group with tiotropium bromide in the treatment scheme, group II Implementation of tiotropium + Symbicort treatment group enabled BiPAP + tiotropium + Symbicort. Results Group comparison indexes of pulmonary function level and lung function indexes were found in the three groups after treatment showed a rising trend comparison between groups after treatment, the levels of the indicators of lung function showed the most significant increases in group I, group II indexes of pulmonary function approximation. In group 6-MWD group with the longest distance difference index (P<0.05), group II and group I but the difference between does not have statistical significance Conclusion BiPAP + tiotropium bromide + Cr is an effective treatment for moderate and severe stable COPD, which is beneficial to improve the quality of life of patients.
